Allan J. Walkey, MD, MSc

Professor, Medicine

Allan Walkey
72 E. Concord St Housman (R)


Dr. Walkey investigates epidemiology and clinical outcomes of complications that occur in patients who are critically ill. Using clinical and administrative data, Dr. Walkey focuses on interations between organ systems during critical illness and seeks to find effective health care provider practice patterns that are associated with better patient outcomes. His research interests include sepsis, acute lung injury, and atrial fibrillation that occurs during critical illness.

Other Positions

  • Associate Professor, Health Law, Policy & Management, Boston University School of Public Health
  • Investigator, Framingham Heart Study
  • Member, Pulmonary Center, Boston University
  • Co-Director, Evans Center for Implementation & Improvement Sciences, Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University


  • University of Massachusetts Medical School, MD
  • Boston University School of Public Health, MS
  • Tufts University, BA


  • Published on 10/1/2023

    Bosch NA, Law AC, Walkey AJ. Immortal Time Bias Possibly Affecting Fludrocortisone-Hydrocortisone Findings-Reply. JAMA Intern Med. 2023 Oct 01; 183(10):1178-1179. PMID: 37669033.

    Read at: PubMed
  • Published on 9/25/2023

    Dinh J, Hinkle CF, Law AC, Walkey AJ, Bosch NA. Effect of Respiratory Viral Panel Adoption on Antibiotic Use in Ventilated Patients. Ann Am Thorac Soc. 2023 Sep 25. PMID: 37748086.

    Read at: PubMed
  • Published on 9/1/2023

    Walkey A, Bosch NA, Teja B. Response. Chest. 2023 Sep; 164(3):e87-e88. PMID: 37689481.

    Read at: PubMed
  • Published on 8/22/2023

    Bosch NA, Law AC, Walkey AJ. Understanding the Facets of Emulating Randomized Clinical Trials. JAMA. 2023 Aug 22; 330(8):770. PMID: 37606680.

    Read at: PubMed
  • Published on 8/17/2023

    Vail EA, Bosch NA, Law AC, Gershengorn HB, Wunsch H, Walkey AJ. Adoption of a Novel Vasopressor Agent in Critically Ill Adults. Ann Am Thorac Soc. 2023 Aug 17. PMID: 37590119.

    Read at: PubMed
  • Published on 8/1/2023

    Gandotra S, Wunsch H, Bosch NA, Walkey AJ, Teja B. Reducing Central Venous Catheter Use through Adoption of Guidelines for Peripheral Catheter-based Vasopressor Delivery. Ann Am Thorac Soc. 2023 Aug; 20(8):1219-1223. PMID: 37220220.

    Read at: PubMed
  • Published on 7/1/2023

    Teja B, Bosch NA, Walkey A. Response. Chest. 2023 Jul; 164(1):e20. PMID: 37423703.

    Read at: PubMed
  • Published on 6/20/2023

    Ofoma UR, Deych E, Mohr NM, Walkey A, Kollef M, Wan F, Joynt Maddox KE. The Relationship Between Hospital Capability and Mortality in Sepsis: Development of a Sepsis-Related Hospital Capability Index. Crit Care Med. 2023 Jun 20. PMID: 37338282.

    Read at: PubMed
  • Published on 6/5/2023

    Zec S, Zorko Garbajs N, Dong Y, Gajic O, Kordik C, Harmon L, Bogojevic M, Singh R, Sun Y, Bansal V, Vu L, Cawcutt K, Litell JM, Redmond S, Fitzpatrick E, Kooda KJ, Biehl M, Dangayach NS, Kaul V, Chae JM, Leppin A, Siuba M, Kashyap R, Walkey AJ, Niven AS. Implementation of a Virtual Interprofessional ICU Learning Collaborative: Successes, Challenges, and Initial Reactions From the Structured Team-Based Optimal Patient-Centered Care for Virus COVID-19 Collaborators. Crit Care Explor. 2023 Jun; 5(6):e0922. PMID: 37637353.

    Read at: PubMed
  • Published on 5/24/2023

    Tekin A, Domecq JP, Valencia Morales DJ, Surapeneni KM, Zabolotskikh IB, Cartin-Ceba R, Clevenbergh P, Mesland JB, Claure-Del Granado R, Gavidia OY, Kumar VK, Kashyap R, Walkey AJ, Gajic O, Odeyemi Y. Biomarker-Concordant Steroid Administration in Severe Coronavirus Disease-2019. J Intensive Care Med. 2023 May 24; 8850666231177200. PMID: 37226483.

    Read at: PubMed

View 262 more publications: View full profile at BUMC

View all profiles